… with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection,
hyperinflammatory states, and at least two of the following signs: fever (body temperature >38C…

… the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with …
SARS-CoV-2 spike protein. *Number of adult patients recruited at a site activated for the tocilizumab …

… network (NJ, USA) considered off-label use of tocilizumab in patients with severe SARS-CoV-2
infection who required intensive care unit (ICU) support. To evaluate treatments for …

… This research revealed an increasing interest in tocilizumab use in COVID-19 pneumonia, …
15 patients with COVID-19 pneumonia at risk for cytokine storm, treatment with tocilizumab …

… for selecting the best candidates for tocilizumab therapy at the time of our case … tocilizumab
may represent an effective and safe option in the treatment of SARS‐CoV‐2‐infected patients …

… -19 in the United States (ie, the number of residents in a defined area with a positive
severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] laboratory test who were …

… outcomes in hospitalized patients with COVID-19 who received tocilizumab. Additional data
… of tocilizumab in decreasing mortality in critically ill adults with COVID-19 in current practice. …

… infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated
… observed in patients with Middle East respiratory syndrome and SARS-CoV-1, 4 Covid-19 …

… acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could de… (CSS) – coronavirus
disease 2019 (hereafter, COVID-19). … neity of symptoms in SARS-CoV-2 infected patients, it is …

… infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is associated
with high mortality rates and places extensive burden on intensive care units to provide …